Tyra Biosciences Inc
TYRA
NASDAQ
Biotechnology
$25.29
USD
+0.27 (+1.08%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.49B
Volume 420.4K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ZYME | Zymeworks Inc | $1.73B | - | +3.3% | - | |
NTLA | Intellia Therapeutics Inc | $1.69B | - | +12.6% | - | |
TRAX | First Tracks Biotherapeutics Inc | $1.67B | - | - | - | |
ANAB | AnaptysBio Inc | $1.65B | - | +107.7% | - | |
FBRX | Forte Biosciences Inc | $1.57B | - | -99.8% | - | |
TYRA | Tyra Biosciences Inc | $1.57B | - | - | - | |
XNCR | Xencor Inc | $1.54B | - | -33.2% | - | |
ABSI | Absci Corp | $1.53B | - | -61.9% | - | |
VIR | Vir Biotechnology Inc | $1.49B | - | +1496.1% | - | |
AVBP | ArriVent BioPharma Inc | $1.44B | - | - | - |
Top Peer by Growth
Vir Biotechnology Inc
+1496.1% YoY Revenue
Best 1-Year Return
Monte Rosa Therapeutics Inc
+258.4% Return